Masimo Price to Book Ratio 2012-2025 | MASI
Historical price to book ratio values for Masimo (MASI) over the last 10 years. The current price to book ratio for Masimo as of January 12, 2026 is 8.77.
| Masimo Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-12 | 132.23 | 8.67 | |
| 2025-09-30 | 147.55 | $15.25 | 9.67 |
| 2025-06-30 | 168.22 | $19.20 | 8.76 |
| 2025-03-31 | 166.60 | $17.46 | 9.54 |
| 2024-12-31 | 165.30 | $19.63 | 8.42 |
| 2024-09-30 | 133.33 | $27.35 | 4.88 |
| 2024-06-30 | 125.94 | $25.73 | 4.89 |
| 2024-03-31 | 146.85 | $25.71 | 5.71 |
| 2023-12-31 | 117.21 | $25.85 | 4.53 |
| 2023-09-30 | 87.68 | $24.16 | 3.63 |
| 2023-06-30 | 164.55 | $24.78 | 6.64 |
| 2023-03-31 | 184.54 | $25.20 | 7.32 |
| 2022-12-31 | 147.95 | $25.50 | 5.80 |
| 2022-09-30 | 141.16 | $23.81 | 5.93 |
| 2022-06-30 | 130.67 | $22.91 | 5.70 |
| 2022-03-31 | 145.54 | $28.50 | 5.11 |
| 2021-12-31 | 292.78 | $28.03 | 10.44 |
| 2021-09-30 | 270.71 | $26.59 | 10.18 |
| 2021-06-30 | 242.45 | $25.27 | 9.59 |
| 2021-03-31 | 229.66 | $24.15 | 9.51 |
| 2020-12-31 | 268.38 | $25.48 | 10.53 |
| 2020-09-30 | 236.06 | $25.70 | 9.19 |
| 2020-06-30 | 227.99 | $24.47 | 9.32 |
| 2020-03-31 | 177.12 | $23.16 | 7.65 |
| 2019-12-31 | 158.06 | $21.75 | 7.27 |
| 2019-09-30 | 148.79 | $20.67 | 7.20 |
| 2019-06-30 | 148.82 | $19.50 | 7.63 |
| 2019-03-31 | 138.28 | $18.84 | 7.34 |
| 2018-12-31 | 107.37 | $18.26 | 5.88 |
| 2018-09-30 | 124.54 | $17.22 | 7.23 |
| 2018-06-30 | 97.65 | $15.82 | 6.17 |
| 2018-03-31 | 87.95 | $14.80 | 5.94 |
| 2017-12-31 | 84.80 | $14.02 | 6.05 |
| 2017-09-30 | 86.56 | $13.88 | 6.24 |
| 2017-06-30 | 91.18 | $13.66 | 6.68 |
| 2017-03-31 | 93.26 | $12.40 | 7.52 |
| 2016-12-31 | 67.40 | $11.16 | 6.04 |
| 2016-09-30 | 59.49 | $6.71 | 8.87 |
| 2016-06-30 | 52.52 | $5.98 | 8.78 |
| 2016-03-31 | 41.84 | $5.47 | 7.65 |
| 2015-12-31 | 41.51 | $5.53 | 7.51 |
| 2015-09-30 | 38.56 | $5.33 | 7.23 |
| 2015-06-30 | 38.74 | $5.57 | 6.95 |
| 2015-03-31 | 32.98 | $6.17 | 5.34 |
| 2014-12-31 | 26.34 | $5.85 | 4.50 |
| 2014-09-30 | 21.28 | $5.42 | 3.93 |
| 2014-06-30 | 23.60 | $5.83 | 4.05 |
| 2014-03-31 | 27.31 | $6.23 | 4.38 |
| 2013-12-31 | 29.23 | $5.76 | 5.07 |
| 2013-09-30 | 26.64 | $5.55 | 4.80 |
| 2013-06-30 | 21.20 | $5.20 | 4.08 |
| 2013-03-31 | 19.62 | $4.96 | 3.96 |
| 2012-12-31 | 21.01 | $4.81 | 4.37 |
| 2012-09-30 | 23.04 | $5.49 | 4.20 |
| 2012-06-30 | 21.33 | $5.16 | 4.13 |
| 2012-03-31 | 22.28 | $4.84 | 4.60 |
| 2011-12-31 | 17.81 | $4.80 | 3.71 |
| 2011-09-30 | 20.61 | $4.96 | 4.16 |
| 2011-06-30 | 28.28 | $4.66 | 6.07 |
| 2011-03-31 | 31.54 | $4.26 | 7.40 |
| 2010-12-31 | 27.70 | $3.87 | 7.16 |
| 2010-09-30 | 25.42 | $4.20 | 6.05 |
| 2010-06-30 | 22.17 | $3.86 | 5.75 |
| 2010-03-31 | 24.72 | $3.55 | 6.97 |
| 2009-12-31 | 26.37 | $5.01 | 5.27 |
| 2009-09-30 | 22.71 | $4.69 | 4.84 |
| 2009-06-30 | 20.90 | $4.40 | 4.75 |
| 2009-03-31 | 25.12 | $4.11 | 6.12 |
| 2008-12-31 | 25.86 | $3.83 | 6.75 |
| 2008-09-30 | 32.25 | $3.75 | 8.60 |
| 2008-06-30 | 29.78 | $3.34 | 8.91 |
| 2008-03-31 | 22.54 | $3.00 | 7.51 |
| 2007-12-31 | 34.20 | $2.74 | 12.46 |
| 2007-09-30 | 22.24 | $2.50 | 8.89 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.103B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $231.230B | 27.48 |
| Intuitive Surgical (ISRG) | United States | $205.316B | 80.33 |
| IDEXX Laboratories (IDXX) | United States | $57.873B | 57.47 |
| Edwards Lifesciences (EW) | United States | $48.171B | 32.30 |
| IQVIA Holdings (IQV) | United States | $41.018B | 22.87 |
| Alcon (ALC) | Switzerland | $39.884B | 26.95 |
| Mettler-Toledo (MTD) | United States | $30.479B | 35.66 |
| DexCom (DXCM) | United States | $27.683B | 38.16 |
| STERIS (STE) | Ireland | $25.594B | 26.42 |
| Waters (WAT) | United States | $23.443B | 31.00 |
| Coloplast (CLPBY) | Denmark | $20.255B | 34.57 |
| Hologic (HOLX) | United States | $16.687B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.899B | 0.00 |
| Penumbra (PEN) | United States | $12.511B | 88.01 |
| Globus Medical (GMED) | United States | $12.276B | 25.76 |
| Sysmex ADR (SSMXY) | Japan | $6.421B | 20.40 |
| Glaukos (GKOS) | United States | $6.370B | 0.00 |
| Teleflex (TFX) | United States | $4.798B | 7.65 |
| TransMedics (TMDX) | United States | $4.602B | 54.52 |
| Veracyte (VCYT) | United States | $3.435B | 39.14 |
| LivaNova (LIVN) | United Kingdom | $3.406B | 18.40 |
| Integer Holdings (ITGR) | United States | $2.928B | 13.74 |
| Alphatec Holdings (ATEC) | United States | $2.613B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.407B | 22.52 |
| Artivion (AORT) | United States | $2.032B | 93.24 |
| UFP Technologies (UFPT) | United States | $1.997B | 26.36 |
| Nihon Kohden (NHNKY) | Japan | $1.986B | 17.34 |
| PROCEPT BioRobotics (PRCT) | United States | $1.751B | 0.00 |
| AxoGen (AXGN) | United States | $1.455B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.448B | 0.00 |
| IRadimed (IRMD) | United States | $1.245B | 59.33 |
| Integra LifeSciences Holdings (IART) | United States | $1.024B | 5.55 |
| OPKO Health (OPK) | United States | $1.021B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.987B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.777B | 0.00 |
| SiBone (SIBN) | United States | $0.775B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.667B | 38.79 |
| Pacific Biosciences Of California (PACB) | United States | $0.607B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.604B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.601B | 0.00 |
| NeuroPace (NPCE) | United States | $0.563B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.556B | 11.08 |
| OrthoPediatrics (KIDS) | United States | $0.504B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.464B | 12.80 |
| ClearPoint Neuro (CLPT) | United States | $0.445B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.420B | 0.00 |
| RxSight (RXST) | United States | $0.415B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.392B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.363B | 60.53 |
| Semler Scientific (SMLR) | United States | $0.344B | 2.57 |
| Spectral Diagnostics (EDTXF) | Canada | $0.299B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.196B | 0.00 |
| CVRx (CVRX) | United States | $0.192B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.187B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.178B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.153B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.150B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.143B | 0.00 |
| LENSAR (LNSR) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.136B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| Solana (HSDT) | United States | $0.133B | 0.00 |
| Hyperfine (HYPR) | United States | $0.099B | 0.00 |
| Accuray (ARAY) | United States | $0.099B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.084B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.065B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.035B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Envoy Medical (COCH) | United States | $0.021B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.46 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |